KEGG   DRUG: Glenzocimab
Entry
D12413                      Drug                                   
Name
Glenzocimab (USAN/INN)
Formula
C2126H3290N574O683S15
Exact mass
48269.6166
Mol weight
48299.31
Sequence
(Heavy chain)
QVQLVQSGAE VKKPGASVKV SCKASGYTFT SYNMHWVRQA PGQGLEWMGG IYPGNGDTSY
NQKFQGRVTM TRDTSTSTVY MELSSLRSED TAVYYCARGT VVGDWYFDVW GQGTLVTVSS
ASTKGPSVFP LAPSSKSTSG GTAALGCLVK DYFPEPVTVS WNSGALTSGV HTFPAVLQSS
GLYSLSSVVT VPSSSLGTQT YICNVNHKPS NTKVDKKVEP KSCDKTH
(Light chain)
DIQMTQSPSS LSASVGDRVT ITCRSSQSLE NSNGNTYLNW YQQKPGKAPK LLIYRVSNRF
SGVPSRFSGS GSGTDFTFTI SSLQPEDIAT YYCLQLTHVP WTFGQGTKVE ITRTVAAPSV
FIFPPSDEQL KSGTASVVCL LNNFYPREAK VQWKVDNALQ SGNSQESVTE QDSKDSTYSL
SSTLTLSKAD YEKHKVYACE VTHQGLSSPV TKSFNRGEC
(Disulfide bridge: H22-H96, H147-H203, H223-L219, L23-L93, L139-L199)
  Type
Peptide
Efficacy
Immunomodulator, Anti-platetet glycoprotein VI antibody
  Type
Monoclonal antibody
Comment
Treatment of the acute phase of ischemic stroke
Target
GP6 [HSA:51206] [KO:K06264]
  Pathway
hsa04512  ECM-receptor interaction
hsa04611  Platelet activation
Brite
Target-based classification of drugs [BR:br08310]
 Not elsewhere classified
  Organismal systems
   Complement and coagulation
    GP6
     D12413  Glenzocimab (USAN/INN)
Other DBs
CAS: 2101829-58-5
PubChem: 497620826
LinkDB

» Japanese version   » Back

DBGET integrated database retrieval system